| 2.05 -0.18 (-8.07%) | 09-10 13:07 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 5.81 | 1-year : | 8.22 |
| Resists | First : | 4.97 | Second : | 7.03 |
| Pivot price | 1.97  |
|||
| Supports | First : | 1.63 | Second : | 1.36 |
| MAs | MA(5) : | 1.96 |
MA(20) : | 2.32 |
| MA(100) : | 5.15 |
MA(250) : | 8.54 |
|
| MACD | MACD : | -0.6 |
Signal : | -0.7 |
| %K %D | K(14,3) : | 33.3 |
D(3) : | 20.5 |
| RSI | RSI(14): 33.3 |
|||
| 52-week | High : | 39.91 | Low : | 1.63 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SKYE ] has closed below upper band by 36.2%. Bollinger Bands are 57.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.24 - 2.25 | 2.25 - 2.25 |
| Low: | 1.86 - 1.87 | 1.87 - 1.88 |
| Close: | 2.21 - 2.23 | 2.23 - 2.25 |
Wed, 09 Sep 2026
$SKYE BIOSCIENCE INC (SKYE.US)$ Now we getting somewhere! [Cheerlead] - Moomoo
Fri, 04 Sep 2026
Skye Bioscience Inc (SKYE) Stock Price, Quote, News & History - Benzinga
Tue, 25 Aug 2026
Skye Bioscience (SKYE) Shares Rise 6% After Hours: Here's What's Driving The Move - webull.com
Thu, 20 Aug 2026
Skye Bioscience (SKYE) insider funds sell 375,840 shares at $0.32–$0.41 - Stock Titan
Thu, 20 Aug 2026
Skye Bioscience (SKYE) 5AM funds sell at penny-level prices - Stock Titan
Wed, 19 Aug 2026
Skye Bioscience receives Nasdaq notice for non-compliance with equity listing rule - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 4 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 4.2 (%) |
| Held by Institutions | 44.4 (%) |
| Shares Short | 150 (K) |
| Shares Short P.Month | 132 (K) |
| EPS | -10.24 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.11 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -95.1 % |
| Return on Equity (ttm) | -233.9 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -10.7 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -39 (M) |
| Levered Free Cash Flow | -19 (M) |
| PE Ratio | -0.21 |
| PEG Ratio | 0 |
| Price to Book value | -18.82 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.24 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|